Barcelona, Catalonia, Spain Grifols appeared to be the Corporate Investor, which was created in 1940. The main office of represented Corporate Investor is situated in the Barcelona. The company was established in Europe in Spain.
For fund there is no match between the country of its foundation and the country of its the most frequent investments - Belgium. Among the most successful fund investment fields, there are Biotechnology, Therapeutics. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Celyad, GigaGen
The typical case for the fund is to invest in rounds with 1-2 participants. Despite the Grifols, startups are often financed by Prolog Ventures, OrbiMed, Fisk Ventures. The meaningful sponsors for the fund in investment in the same round are Hunza Ventures, Life Sciences Research Partners V.Z.W.. In the next rounds fund is usually obtained by Perceptive Advisors, Hunza Ventures.
The typical startup value when the investment from Grifols is 10-50 millions dollars. Deals in the range of 10 - 50 millions dollars are the general things for fund. Opposing the other organizations, this Grifols works on 9 percentage points less the average amount of lead investments. Considering the real fund results, this Corporate Investor is 40 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2009. The higher amount of exits for fund were in 2015.
Related Funds
| Fund Name | Location |
| Aries Holding BV | Amsterdam, Noord-Holland, The Netherlands |
| Bitpie | Australia, New South Wales, Sydney |
| Cellular Bioengineering | Hawaii, Honolulu, United States |
| EDEX | - |
| SAYJ Global Partners | - |
| Sky9 Capital | China, Shanghai, Shanghai |
| Stripes | New York, New York, United States |
| Tao Group | Las Vegas, Nevada, United States |
| TechBloc | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Celyad | $8M | 19 Jan 2009 | Walloon Brabant |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Celyad | $8M | 19 Jan 2009 | Walloon Brabant |
